References
Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin. 2013;63(1):11–30.
Gurusamy KS, Kumar S. Davidson BR Prophylactic gastrojejunostomy for unresectable periampullary carcinoma. Cochrane Database Syst Rev. 2010;10:CD008533. doi:10.1002/14651858.CD008533.pub2.
Yeo CJ, Sohn TA, Cameron JL, Hruban RH, Lillemoe KD, Pitt HA. Periampullary adenocarcinoma: analysis of 5-year survivors. Ann Surg. 1998;227(6):821–31.
Onkendi EO, Boostrom SY, Sarr MG, Farnell MB, Nagorney DM, Donohue JH, et al. 15-year experience with surgical treatment of duodenal carcinoma: a comparison of periampullary and extra-ampullary duodenal carcinomas. J Gastrointest Surg. 2012;16(4):682–91. doi:10.1007/s11605-011-1808-z.
Michelassi F, Erroi F, Dawson PJ, Pietrabissa A, Noda S, Handcock M, et al. Experience with 647 consecutive tumors of the duodenum, ampulla, head of the pancreas, and distal common bile duct. Annals of Surgery. 1989;210(4):544–54.
Marsh Rde W, Alonzo M, Bajaj S, Baker M, Elton E, Farrell TA, et al. Comprehensive review of the diagnosis and treatment of biliary tract cancer 2012. Part II: multidisciplinary management. J Surg Oncol. 2012;106(3):339–45. doi:10.1002/jso.23027.
Shepherd HA, Royle G, Ross AP, et al. Endoscopic biliary endoprosthesis in the palliation of malignant obstruction of the distal common bile duct: a randomized trial. Br J Surg. 1988;75:1166–8.
Cho YK, Kim JK, Kim MY, et al. Systematic review of randomized trials for hepatocellular carcinoma treated with percutaneous ablation therapies. Hepatology. 2009;49:453–9.
Mulier S, Ruers T, Jamart J, et al. Radiofrequency ablation versus resection for resectable colorectal liver metastases: time for a randomized trial? An update. Dig Surg. 2008;25:445–60.
Steel AW, Postgate AJ, Khorsandi S, Nicholls J, Jiao L, Vlavianos P, et al. Endoscopically applied radiofrequency ablation appears to be safe in the treatment of malignant biliary obstruction. Gastrointest Endosc. 2011;73(1):149–53. doi:10.1016/j.gie.2010.09.031.
Itoi T, Isayama H, Sofuni A, et al. Evaluation of effects of a novel endoscopically applied radiofrequency ablation biliary catheter using an ex-vivo pig liver. J Hepatobiliary Pancreat Sci. 2012;19:543–7.
Zacharoulis D, Lazoura O, Sioka E, et al. Habib EndoHPB: a novel endobiliary radiofrequency ablation device. An experimental study. J Invest Surg. 2013;26:6–10.
Figueroa-Barojas P, Bakhru MR, Habib N, et al. Safety and efficacy of radiofrequency ablation in the management of unresectable bile duct and pancreatic cancer: a novel palliation technique. Gastrointest Endosc. 2011;73(4S):AB127.
Watson JB, Habr FG. Safety and efficacy of endoscopic radiofrequency ablation in non-resectable cholangiocarcinoma, a case series. Program No. P108. ACG 2012 Annual Scientific Meeting Abstracts. Las Vegas: American College of Gastroenterology; 2012
Mizandari M, Pai M, Xi F, Valek V, Tomas A, Quaretti P, et al. Percutaneous intraductal radiofrequency ablation is a safe treatment for malignant biliary obstruction: feasibility and early results. Cardiovasc Intervent Radiol. 2012;36(3):814–9.
Mukund A, Arora A, Rajesh S, et al. Endobiliary radiofrequency ablation for reopening of occluded biliary stents: a promising technique. J Vasc Interv Radiol. 2013;24:142–4.
Pozsár J, Tarpay Á, Burai J, Pap Á. Intraductal radiofrequency ablation can restore patency of occluded biliary self-expanding metal stents. Z Gastroenterol. 2011;49:A70.
Conflict of Interest
The authors have no conflict of interest to declare.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mao, E.J., Watson, J.B., Soares, G. et al. Successful Percutaneous Endobiliary Radiofrequency Ablation for Unresectable Malignant Biliary Obstruction: A Case Report and Review of the Literature. J Gastrointest Canc 45 (Suppl 1), 55–57 (2014). https://doi.org/10.1007/s12029-013-9538-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12029-013-9538-y